Retatrutide is a high-purity research-only peptide studied for its multi-receptor agonist activity involving glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This peptide is utilized in laboratory research focused on advanced metabolic regulation, energy balance, and endocrine signaling pathways.

Retatrutide is designed for researchers investigating tri-agonist incretin signaling mechanisms and their influence on glucose metabolism, lipid pathways, and systemic metabolic signaling in controlled research environments.

Key Research Characteristics

Retatrutide – A tri-agonist peptide studied for its interaction with GLP-1, GIP, and glucagon receptors and downstream metabolic and endocrine signaling pathways.

Research Focus Areas

• Tri-agonist incretin receptor signaling

• Metabolic and endocrine pathway research

• Energy balance and lipid signaling studies

• Peptide-receptor interaction analysis

Quality & Specifications

• High-purity Retatrutide (≥99%)

• Lyophilized for laboratory stability

• Independently tested for identity and purity

• Manufactured in controlled research-grade facilities

Important Notice

For Research Use Only.

This product is not intended for human or animal consumption, clinical use, or diagnostic purposes. Intended exclusively for qualified researchers conducting laboratory research.